NGS-based RNA-seq Market (Updated Version Available)

The prime objective of this report is to help the user understand the market in terms of its definition, segmentation, market potential, influential trends, and the challenges that the market is facing with 10 major regions and 30 major countries. Deep researches and analysis were done during the preparation of the report. The readers will find this report very helpful in understanding the market in depth. The data and the information regarding the market are taken from reliable sources such as websites, annual reports of the companies, journals, and others and were checked and validated by the industry experts. The facts and data are represented in the report using diagrams, graphs, pie charts, and other pictorial representations. This enhances the visual representation and also helps in understanding the facts much better. Factors such as the advantages of RNA-seq over microarray technology, technological advancements in RNA-seq products, increasing number of RNA-seq grants, increasing number of research activities, and rapid growth in precision medicine are driving the growth of the NGS-based RNA-seq market.
The hospitals and clinics segment is expected to register the highest growth due to the growing number of agreements between companies and hospitals for the development of advanced tests and products catering to the specific needs of hospitals and clinics.

The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading NGS-based RNA-seq by geography. The report splits the market size, by volume and value, on the basis of application type and geography.

The report forecast global NGS-based RNA-seq market to grow to reach xxx Million USD in 2020 with a CAGR of xx% during the period 2021-2028.

Note – In order to provide more accurate market forecast, all our reports will be updated before delivery by considering the impact of COVID-19.

First, this report covers the present status and the future prospects of the global NGS-based RNA-seq market for 2015-2028.
In this report, we analyze global market from 5 geographies: Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia], Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland], North America[United States, Canada, Mexico], Middle East & Africa[GCC, North Africa, South Africa], South America[Brazil, Argentina, Columbia, Chile, Peru].

Key Companies
Illumina
Thermo Fisher Scientific
Pacific Biosciences Of California
Qaigen
F. Hoffmann-La Roche
Agilent Technologies
Oxford Nanopore Technologies
Perkinelmer
Eurofins Scientific
Gatc Biotech
Macrogen

At the same time, we classify NGS-based RNA-seq according to the type, application by geography. More importantly, the report includes major countries market based on the type and application.

Market by Order Type
SBS
SMRT
Market by Application
Transcriptome Epigenetics
Small RNA

Market Segment as follows:
By Region
Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia]
Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland]
North America[United States, Canada, Mexico]
Middle East & Africa[GCC, North Africa, South Africa]
South America[Brazil, Argentina, Columbia, Chile, Peru]

The research provides answers to the following key questions:
• What is the estimated growth rate and market share and size of the NGS-based RNA-seq market for the forecast period 2021 - 2028?
• What are the driving forces in the NGS-based RNA-seq market for the forecast period 2021 - 2028?
• Who are the prominent market players and how have they gained a competitive edge over other competitors?
• What are the market trends influencing the progress of the NGS-based RNA-seq industry worldwide?
• What are the major challenges and threats restricting the progress of the industry?
• What opportunities does the market hold for the prominent market players?

For any other requirements, please feel free to contact us and we will provide you customized report.